Literature DB >> 34423473

Mechano-energetic aspects of Barth syndrome.

Jan Dudek1, Christoph Maack1.   

Abstract

Energy-demanding organs like the heart are strongly dependent on oxidative phosphorylation in mitochondria. Oxidative phosphorylation is governed by the respiratory chain located in the inner mitochondrial membrane. The inner mitochondrial membrane is the only cellular membrane with significant amounts of the phospholipid cardiolipin, and cardiolipin was found to directly interact with a number of essential protein complexes, including respiratory chain complexes I to V. An inherited defect in the biogenesis of cardiolipin causes Barth syndrome, which is associated with cardiomyopathy, skeletal myopathy, neutropenia and growth retardation. Energy conversion is dependent on reducing equivalents, which are replenished by oxidative metabolism in the Krebs cycle. Cardiolipin deficiency in Barth syndrome also affects Krebs cycle activity, metabolite transport and mitochondrial morphology. During excitation-contraction coupling, calcium (Ca2+ ) released from the sarcoplasmic reticulum drives sarcomeric contraction. At the same time, Ca2+ influx into mitochondria drives the activation of Krebs cycle dehydrogenases and the regeneration of reducing equivalents. Reducing equivalents are essential not only for energy conversion, but also for maintaining a redox buffer, which is required to detoxify reactive oxygen species (ROS). Defects in CL may also affect Ca2+ uptake into mitochondria and thereby hamper energy supply and demand matching, but also detoxification of ROS. Here, we review the impact of cardiolipin deficiency on mitochondrial function in Barth syndrome and discuss potential therapeutic strategies.
© 2021 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Entities:  

Keywords:  Barth syndrome; cardiolipin; mitochondria; reactive oxygen species; respiratory chain

Mesh:

Substances:

Year:  2021        PMID: 34423473     DOI: 10.1002/jimd.12427

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  2 in total

Review 1.  Myocardial disturbances of intermediary metabolism in Barth syndrome.

Authors:  Amanda A Greenwell; Seyed Amirhossein Tabatabaei Dakhili; John R Ussher
Journal:  Front Cardiovasc Med       Date:  2022-08-10

2.  Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome.

Authors:  Amanda A Greenwell; Seyed Amirhossein Tabatabaei Dakhili; Keshav Gopal; Christina T Saed; Jordan S F Chan; Nick Kazungu Mugabo; Pavel Zhabyeyev; Farah Eaton; Jennifer Kruger; Gavin Y Oudit; John R Ussher
Journal:  Front Cardiovasc Med       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.